Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1, Open-Label, Multicenter Study of INCA00186 as Monotherapy or in Combination With Immunotherapy in Participants With Advanced Solid Tumors

NCT04989387 is registered in ClinicalTrials.gov with Incyte Corporation as lead sponsor.

NCT NCT04989387
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04989387 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1, Open-Label, Multicenter Study of INCA00186 as Monotherapy or in Combination With Immunotherapy in Participants With Advanced Solid Tumors
Lead sponsor
Incyte Corporation
Phase
Phase 1
Overall status
Terminated
Start date
October 4, 2021
Completion date
September 19, 2024
Enrollment
57 (actual)
Sites
32

Conditions

As the registry lists them; a condition with its own page is linked.

advanced solid tumors, gastrointestinal (gi) malignancies, squamous cell carcinoma of the head and neck (scchn)